Use of E-cigarettes and Other Tobacco Products and Progression to Daily Cigarette Smoking.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Pierce (2021)
Vapers exhibit similar subjective nicotine dependence but lower nicotine reinforcing value compared to smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Rycroft (2021)
association of initial e-cigarette and other tobacco product use with subsequent cigarette smoking in adolescents: a cross-sectional, matched control study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Shahab (2021)
Smoking Trajectories of adult Never Smokers 12 Months after First Purchase of a JUUL Starter Kit.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Shiffman (2021)
The first nicotine product tried is associated with current multiple nicotine product use and nicotine dependence among a nationally representative sample of U.S. youths.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Simon (2023)
“I cannot live without my vape”: Electronic cigarette user-identified indicators of vaping dependence.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Soule (2020)
Nicotine Pouch: awareness, Beliefs, Use, and Susceptibility among Current Tobacco Users in the United States, 2021
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Sparrock (2023)
assessment of the abuse liability of three menthol Vuse Solo electronic cigarettes relative to combustible cigarettes and nicotine gum
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Stiles (2018)
Youth use of e-cigarettes: Does dependence vary by device type?
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Tackett (2021)
The role of E-liquid vegetable glycerin and exhaled aerosol on cue reactivity to tank-based electronic nicotine delivery systems (ENDS).
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Vena (2019)